The stability of L-glutamine in total parenteral nutrition solutions
- PMID: 16839918
- DOI: 10.1016/0261-5614(91)90038-e
The stability of L-glutamine in total parenteral nutrition solutions
Abstract
An assessment was made over a period of 14 days of the rate of glutamine degradation in different intravenous solutions kept at 22-24 degrees C, 4 degrees C, -20 degrees C and -80 degrees C. At room temperature (22-24 degrees C) degradation rates in mixed parenteral nutrition solutions and aminoacid/dextrose solutions ranged from 0.7-0.9%/day, in Perifusin 0.6%/day, and in dextrose alone as low as 0.15%/day. At 4 degrees C, glutamine degradation was <0.1-0.2%/day in all solutions examined, at -20 degrees C it was minimal (<0.04%/day) and at -80 degrees C, it was undetectable. Glutamine degradation was found to be associated with the formation of equimolar quantities of ammonia. No glutamate formation was detected. It is concluded that it is possible to store glutamine in parenteral nutrition solutions kept at 4 degrees C, with about 2% loss over a period of 14 days. The degradation is sufficiently slow to consider the use of intravenous glutamine in nutritional therapy.
Similar articles
-
Factors affecting the stability of L-glutamine in solution.Clin Nutr. 1991 Aug;10(4):186-92. doi: 10.1016/0261-5614(91)90037-d. Clin Nutr. 1991. PMID: 16839917
-
[Effects of glutamine supplemented parenteral nutrition on the incidence of necrotizing enterocolitis, nosocomial sepsis and length of hospital stay in very low birth weight infants].Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 1):325-33. Med Wieku Rozwoj. 2005. PMID: 16547380 Clinical Trial. Polish.
-
[Parenteral glutamine does not improve the nutritional status in patients during high-dose chemotherapy and autologous peripheral stem cell transplantation].Vnitr Lek. 2002 Nov;48(11):1039-48. Vnitr Lek. 2002. PMID: 12577455 Clinical Trial. Czech.
-
Parenteral nutrition: current status and concepts.Drugs. 1982 Apr;23(4):276-323. doi: 10.2165/00003495-198223040-00003. Drugs. 1982. PMID: 6806063 Review.
-
Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.Clin Nutr ESPEN. 2017 Feb;17:75-85. doi: 10.1016/j.clnesp.2016.09.007. Epub 2016 Oct 27. Clin Nutr ESPEN. 2017. PMID: 28361751 Review.
Cited by
-
Arginyl-glutamine dipeptide or docosahexaenoic acid attenuates hyperoxia-induced small intestinal injury in neonatal mice.J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):499-504. doi: 10.1097/MPG.0b013e3182330867. J Pediatr Gastroenterol Nutr. 2012. PMID: 22020559 Free PMC article.
-
The role of glutamine in the immune system and in intestinal function in catabolic states.Amino Acids. 1994 Oct;7(3):231-43. doi: 10.1007/BF00807699. Amino Acids. 1994. PMID: 24186121
-
MoGLN2 Is Important for Vegetative Growth, Conidiogenesis, Maintenance of Cell Wall Integrity and Pathogenesis of Magnaporthe oryzae.J Fungi (Basel). 2021 Jun 8;7(6):463. doi: 10.3390/jof7060463. J Fungi (Basel). 2021. PMID: 34201222 Free PMC article.
-
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.Gut. 2001 Jan;48(1):28-33. doi: 10.1136/gut.48.1.28. Gut. 2001. PMID: 11115819 Free PMC article. Clinical Trial.
-
Effect of taurine, L-glutamine and L-histidine addition in an amino acid glucose solution on the cellular bioavailability of zinc.Biometals. 1994 Jul;7(3):237-43. doi: 10.1007/BF00149554. Biometals. 1994. PMID: 8043989
LinkOut - more resources
Full Text Sources